Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Interest Coverage Ratio (2016 - 2025)

Tg Therapeutics has reported Interest Coverage Ratio over the past 9 years, most recently at 7.73 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 7.73 for Q4 2025, up 926.27% from a year ago — trailing twelve months through Dec 2025 was 4.61 (up 1973.86% YoY), and the annual figure for FY2025 was 4.61, up 1962.7%.
  • Interest Coverage Ratio for Q4 2025 was 7.73 at Tg Therapeutics, up from 4.37 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for TGTX hit a ceiling of 30.91 in Q3 2023 and a floor of 86.14 in Q4 2021.
  • Median Interest Coverage Ratio over the past 5 years was 8.73 (2023), compared with a mean of 16.59.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 109.22% in 2021 and later soared 926.27% in 2025.
  • Tg Therapeutics' Interest Coverage Ratio stood at 86.14 in 2021, then soared by 68.55% to 27.09 in 2022, then skyrocketed by 81.04% to 5.14 in 2023, then surged by 81.79% to 0.94 in 2024, then soared by 926.27% to 7.73 in 2025.
  • The last three reported values for Interest Coverage Ratio were 7.73 (Q4 2025), 4.37 (Q3 2025), and 5.19 (Q2 2025) per Business Quant data.